Cargando…

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?

Detalles Bibliográficos
Autores principales:	Wood, Oliver WG, Yeung, Jason HY, Kwakowsky, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154468/ https://www.ncbi.nlm.nih.gov/pubmed/36751792 http://dx.doi.org/10.4103/1673-5374.363834

Ejemplares similares

EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review
por: Wood, Oliver W. G., et al.
Publicado: (2022)

Metabotropic glutamate receptor 1 alpha: a unique receptor variant with variable implications for Alzheimer’s disease pathogenesis
por: Yeung, Jason HY, et al.
Publicado: (2023)

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

iGluR expression in the hippocampal formation, entorhinal cortex, and superior temporal gyrus in Alzheimer’s disease
por: Yeung, Jason HY, et al.
Publicado: (2022)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease
por: Takahashi, Kou, et al.
Publicado: (2015)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway
por: Kwakowsky, Andrea, et al.
Publicado: (2018)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
por: Parkin, Georgia M, et al.
Publicado: (2018)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

Neurovascular ageing: transcriptomic readout and implications on therapeutic targeting in Alzheimer's disease
por: Li, Zhongqi, et al.
Publicado: (2021)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4
por: Almilaji, Ahmad, et al.
Publicado: (2013)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer´s disease
por: Fernández-Vega, Iván, et al.
Publicado: (2020)

Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies
por: Zhang, Jie, et al.
Publicado: (2021)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Glutamate Transporters EAAT4 and EAAT5 Are Expressed in Vestibular Hair Cells and Calyx Endings
por: Dalet, Antoine, et al.
Publicado: (2012)

hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer’s disease and potential therapeutics
por: TCW, Julia, et al.
Publicado: (2023)

Transcranial photobiomodulation with near-infrared light: a promising therapeutic modality for Alzheimer’s disease
por: Liu, Hanli, et al.
Publicado: (2023)

The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression
por: Kwakowsky, Andrea, et al.
Publicado: (2020)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Glutamate Transporters EAAT2 and EAAT5 Differentially Shape Synaptic Transmission from Rod Bipolar Cell Terminals
por: Tang, Fu-Sheng, et al.
Publicado: (2022)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

New unexpected role for Wolfram Syndrome protein WFS1: a novel therapeutic target for Alzheimer’s disease?
por: Chen, Shuo, et al.
Publicado: (2022)

Melastatin-related transient receptor potential 2 channel in Aβ(42)-induced neuroinflammation: implications to Alzheimer’s disease mechanism and development of therapeutics
por: Wei, Linyu, et al.
Publicado: (2018)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease
por: Tamagno, Elena, et al.
Publicado: (2021)

Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer’s Disease?
por: Mills, Zoe B., et al.
Publicado: (2023)

PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease
por: Perrin, Florian, et al.
Publicado: (2023)

Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer’s Disease Therapy
por: Wostyn, Peter, et al.
Publicado: (2011)

Tetrahydrohyperforin (IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapy
por: González, Alexis, et al.
Publicado: (2016)

Potential therapeutic interventions based on the role of the endoplasmic reticulum stress response in progressive neurodegenerative diseases
por: Puri, Basant K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oimi4bs6cnl2seql8vfv2n9i2t